Development of a National Cancer Registry in a Low Resourced Country: The Case of Kenya National Cancer Registry Programme Background: Pancreatic cancer is the fourth leading cause of cancer ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Although percutaneous liver biopsy is still the “gold standard,” advances in techniques and ...

YOKNEAM, Israel, May 2, 2022 /PRNewswire/ -- Limaca Medical ("Limaca") announced today that its Precision-GI™ Endoscopic Ultrasound Biopsy Product has received a Breakthrough Device Designation from ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Limaca Medical’s Precision GI endoscopic ultrasound biopsy device, following ...

Agriline and Trendlines led the round for this major leap in endoscopic ultrasound-guided biopsy devices for improved diagnosis of gastrointestinal and other solid tumor cancers MISGAV, Israel, Nov.

Compared with no ureteroscopy or percutaneous biopsy, ureteroscopic biopsy in patients with upper tract urothelial carcinoma was significantly associated with a 40% increased risk for intravesical ...

Limaca Medical Ltd. received U.S. FDA 510(k) clearance for its Precision for gastrointestinal (GI) endoscopic ultrasound (EUS) biopsy device which the company said allows for faster, more efficient ...

Comprehensive genomic profiling (CGP) of advanced stage esophageal squamous cell carcinomas (ESCC) and esophageal adenocarcinomas (EAC) to reveal similarities and differences. INTEGRATE: A randomized ...

CMS Transitional Pass-Through (TPT) Payment and completion of successful clinical studies position Limaca for US market entry. YOKNEAM, Israel, Feb. 18, 2025 /PRNewswire/ -- Limaca Medical Ltd.

Uncontrolled and abnormal growth of cells in the pancreas can lead to pancreatic cancer. Healthcare professionals may use endoscopies to help diagnose pancreatic cancer. According to the American ...